-
The FDA has approved the combination of dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate.
-
Allergic rhinitis is often treated successfully with antihistamines and local corticosteroids, but because of inadequate symptom control, patient preference, or both, sometimes allergen desensitization becomes preferable.
-
Pulmonary crackles (the physical finding previously known as râles, French for "rattle") are commonly sought to confirm a diagnosis of heart failure (HF) and can be fine, medium, or coarse. However, crackles can occur in other diseases (interstitial lung disease, asbestosis, alveolitis, and bronchiectasis) and in presumably normal people.
-
This group of health policy leaders sought to learn the proportion of physicians who are currently using electronic health records, whether they were satisfied with the systems they used, and what impact the physicians believe that these systems have on quality of patient care.
-
Enthusiasm for coronary artery bypass grafting (CABG) as an intervention for cardiovascular disease has been tempered by concerns about postoperative cognitive decline.
-
The 12-lead ECG and lead II rhythm strip in the Figure were obtained from a 83-year old woman who presented with rapid heart rate. She was on no antiarrhythmic medications. How would you interpret her ECG?
-
Shingles vaccine added to CDC list of vaccines for adults 60 and older; CDC recommends Tdap for postpartum women; new study suggests sequential therapy with antibiotics for H. pylori may be more effective than standard therapy; FDA Actions.
-
Standard eradication therapy for H. pylori in the U.S. has involved use of a proton pump inhibitor (PPI) plus clarithromycin and either amoxicillin or an imidazole (metronidazole).
-
After 7.3 years of treatment and follow-up, a combination pill of folic acid, vitamin B6 and vitamin B12 did not reduce a combined endpoint of total cardiovascular events among high-risk women despite significant homocysteine lowering.
-
Duloxetine is the first serotonin norepinephrine reuptake inhibitor (SNRI) to be approved for the treatment of fibromyalgia.
